Preview Mode Links will not work in preview mode

Keeping Current CME

Feb 28, 2023

How can initial myeloma therapy be tailored to the individual patient? Our experts provide practical guidance.
  
Credit available for this activity expires: [02/27/2024]
Earn Credit / Learning Objectives & Disclosures:


Feb 22, 2023

At least 5 agents that target the peroxisome proliferator-activated receptor (PPAR) are in clinical studies in primary biliary cholangitis (PBC). Are you aware of the latest data?
  
Credit available for this activity expires: 2/21/2024
Earn Credit / Learning Objectives & Disclosures:


Feb 1, 2023

What’s new in FLT3 acute myeloid leukemia (AML)? Join to hear a panel of experts discuss how they use FLT3 inhibitors in patients with AML.

Credit available for this activity expires: 1/30/2024
Earn Credit / Learning Objectives & Disclosures: